Skip to main content

Table 3 Univariate and multivariate analysis for rehospitalisation for HF

From: Impact of autoantibodies against the M2-muscarinic acetylcholine receptor on clinical outcomes in peripartum cardiomyopathy patients with standard treatment

 

Univariate analysis

Multivariate analysis

 

OR

95% CI

p value

OR

95% CI

p value

LVEDD

1.1

1.02–1.20

0.015

   

LVEF

9.7

2.7–35.1

0.001

5.1

1.2–21.4

0.026

NT-proBNP

8.6

1.8–41.3

0.007

7.6

1.4–41.4

0.019

Dosages of metoprolol

0.88

0.79–0.98

0.015

   

Anti-M2-R

5.0

1.3–19.4

0.020

5.2

1.1–23.6

0.033

  1. OR odds ratio, CI confidence interval, LVEDD left ventricular end-diastolic diameter, LVEF left ventricular ejection fraction, NT-proBNP N-terminal pro-brain natriuretic peptide, Anti-M2-R autoantibodies against the M2-muscarinic receptor
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us